Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine timing for laryngoscopy stress response
NCT07165483Recruiting
- Sponsor
- Tanta University
- Start
- Sep 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine (3 arms), sponsored by Tanta University. Primary endpoint: Mean Arterial Pressure up to 2 hours. Started Sep 2025; status: recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT07165483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07165483.